Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users

Bansal, 2004, Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them?, Nicotine & Tobacco Research, 6, S303, 10.1080/14622200412331320707 Bernat, 2017, US adult tobacco users’ absolute harm perceptions of traditional and alternative tobacco products, information-seeking behaviors, and (mis)beliefs about chemicals in tobacco products, Addictive Behaviors, 71, 38, 10.1016/j.addbeh.2017.02.027 Bondy, 2009, Origin and use of the 100 cigarette criterion in tobacco surveys, Tobacco Control, 18, 317, 10.1136/tc.2008.027276 Borland, 2012, Effects of a Fact Sheet on beliefs about the harmfulness of alternative nicotine delivery systems compared with cigarettes, Harm Reduction Journal, 9, 19, 10.1186/1477-7517-9-19 Byrne, 2012, The unintended consequences of disclosure: Effect of manipulating sponsor identification on the perceived credibility and effectiveness of smoking cessation advertisements, Journal of Health Communication, 17, 1119, 10.1080/10810730.2012.665425 Choi, 2012, Young adults’ favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: Findings from a focus group study, American Journal of Public Health, 102, 2088, 10.2105/AJPH.2011.300525 Czoli, 2017, How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes, Tobacco Control, 26, e49, 10.1136/tobaccocontrol-2016-053060 Davis, 2006, Low literacy impairs comprehension of prescription drug warning labels, Journal of General Internal Medicine, 21, 847, 10.1111/j.1525-1497.2006.00529.x Family Smoking Prevention and Tobacco Control Act. (2009). Title 21 U.S.C. 301. Public Law 111-31. Available at: https://www.govinfo.gov/content/pkg/PLAW-111publ31/html/PLAW-111publ31.htm. Feirman, 2018, Monitoring harm perceptions of smokeless tobacco products among US adults: Health Information National Trends Survey 2012, 2014, 2015, Addictive Behaviors, 77, 7, 10.1016/j.addbeh.2017.09.002 Ferguson, 2011, Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt, Addictive Behaviors, 36, 713, 10.1016/j.addbeh.2011.02.002 Fix, 2017, Evaluation of modified risk claim advertising formats for Camel Snus, Health Education Journal, 76, 971, 10.1177/0017896917729723 Fong, 2019, US adult perceptions of the harmfulness of tobacco products: Descriptive findings from the 2013–14 baseline wave 1 of the PATH study, Addictive Behaviors, 91, 180, 10.1016/j.addbeh.2018.11.023 Gerlach, 2019, Assessing likelihood of product use for snus modified-risk information among adult current cigarette smokers, former tobacco users, and never tobacco users, Addictive Behaviour Reports, 10 Haddock, 2004, Modified tobacco use and lifestyle change in risk-reducing beliefs about smoking, American Journal of Preventive Medicine, 27, 35, 10.1016/j.amepre.2004.03.010 Heavner, 2009, Survey of smokers’ reasons for not switching to safer sources of nicotine and their willingness to do so in the future, Harm Reduction Journal, 6, 14, 10.1186/1477-7517-6-14 Kaufman, 2014, Judgments, awareness, and the use of snus among adults in the United States, Nicotine & Tobacco Research, 16, 1404, 10.1093/ntr/ntu116 Kiviniemi, 2015, Deficiencies in public understanding about tobacco harm reduction: Results from a United States national survey, Harm Reduction Journal, 12, 21, 10.1186/s12954-015-0055-0 Lee, 2013, The effect on health of switching from cigarettes to snus - a review, Regulatory Toxicology and Pharmacology, 66, 1, 10.1016/j.yrtph.2013.02.010 Levy, 2004, The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts, Cancer Epidemiology, Biomarkers & Prevention, 13, 2035, 10.1158/1055-9965.2035.13.12 Liu, 2015, Risk perceptions of smokeless tobacco among adolescent and adult users and nonusers, Journal of Health Communication, 20, 599, 10.1080/10810730.2015.1012237 Lund, 2014, Perceptions of relative risk of disease and addiction from cigarettes and snus, Psychology of Addictive Behaviors, 28, 367, 10.1037/a0032657 McCormack, 2016, Consumer understanding, preferences, and responses to different versions of drug safety messages in the United States: A randomized controlled trial, Drug Safety, 39, 171, 10.1007/s40264-015-0358-9 Nutt, 2014, Estimating the harms of nicotine-containing products using the MCDA approach, European Addiction Research, 20, 218, 10.1159/000360220 O'Connor, 2005, Smoker awareness of and beliefs about supposedly less-harmful tobacco products, American Journal of Preventive Medicine, 29, 85, 10.1016/j.amepre.2005.04.013 Owusu, 2019, Trends in trust in the sources of health information on e-cigarettes among US adults, 2015–2017, American Journal of Public Health, 109, 145, 10.2105/AJPH.2018.304754 Peiper, 2010, University faculty perceptions of the health risks related to cigarettes and smokeless tobacco, Drug and Alcohol Review, 29, 121, 10.1111/j.1465-3362.2009.00143.x Pepper, 2015, How risky is it to use e-cigarettes? Smokers’ beliefs about their health risks from using novel and traditional tobacco products, Journal of Behavioral Medicine, 38, 318, 10.1007/s10865-014-9605-2 Popova, 2013, Perceptions of relative risk of snus and cigarettes among US smokers, American Journal of Public Health, 103, e21, 10.2105/AJPH.2013.301547 Raymond, 2002, Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product, Obstetrics and Gynecology, 100, 342 Regan, 2012, Smokeless and flavored tobacco products in the US: 2009 Styles survey results, American Journal of Preventive Medicine, 42, 29, 10.1016/j.amepre.2011.08.019 Shiffman, 2008, Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: Relationship with use and compliance, Addiction, 103, 1371, 10.1111/j.1360-0443.2008.02268.x Shiffman, 2011, Consumer understanding of prescription drug information: An illustration using an antidepressant medication, Annals of Pharmacotherapy, 45, 452, 10.1345/aph.1P477 Sullivan, 2015, Communicating benefit and risk information in direct- to-consumer print advertisements – A randomized study, Therapeutic Innovation & Regulatory Science, 49, 493, 10.1177/2168479015572370 US Department of Health and Human Services. (2010). Guidance for Industry. Label Comprehension Studies for Nonprescription Drug Products. Silver Spring, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, Food and Drug Administration, Center for Drug Evaluation and Research. Available at: https://www.fda.gov/media/75626/download. US Department of Health and Human Services. (2012). Guidance for Industry. Modified Risk Tobacco Product Applications. Draft Guidance. US Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products. Available at: https://www.fda.gov/downloads/TobaccoProducts/Labeling/RulesRegulationsGuidance/UCM297751.pdf. US Department of Health and Human Services. (2014). The Health Consequences of Smoking – 50 Years Of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Available at: https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf. US Department of Health and Human Services, 2017, Federal Policy for the Protection of Human Subjects. Final rule, Federal Register, 82, 7149 US Food and Drug Administration. (2018a). Smokeless Tobacco Labeling and Warning Statement Requirements. Available at: https://www.fda.gov/tobacco-products/labeling-and-warning-statements-tobacco-products/smokeless-tobacco-labeling-and-warning-statement-requirements. US Food and Drug Administration. (2018b). RJ Reynolds Tobacco Company Modified Risk Tobacco Product (MRTP) Applications. Camel Snus Modified Risk Advertising: Comprehension and Perceptions among Tobacco Users and Non-Users. Available at: https://digitalmedia.hhs.gov/tobacco/static/mrtpa/RJR/6_RESEARCH/7%20Section%206.2%20-%20Comprehension%20and%20Perception_Release%20in%20Full.pdf. Wackowski, 2016, Comparison of direct and indirect measures of e-cigarette risk perceptions, Tobacco Regulatory Science, 2, 38, 10.18001/TRS.2.1.4 Wackowski, 2016, Young adults’ risk perceptions of various tobacco products relative to cigarettes: Results from the National Young Adult Health Survey, Health Education & Behavior, 43, 328, 10.1177/1090198115599988 Wackowski, 2016, Smokers’ and e-cigarette users’ perceptions of modified risk warnings for e-cigarettes, Preventive Medicine Reports, 4, 309, 10.1016/j.pmedr.2016.07.005 Wackowski, 2019, Smokers’ perceptions of risk and harm from snus relative to cigarettes. A latent profile analysis study, Addictive Behaviors, 91, 171, 10.1016/j.addbeh.2018.11.011 Weiss, 2005, Quick assessment of literacy in primary care: The Newest Vital Sign, The Annals of Family Medicine, 3, 514, 10.1370/afm.405 Wolf, 2006, Misunderstanding of prescription drug warning labels among patients with low literacy, American Journal of Health System Pharmacy, 63, 1048, 10.2146/ajhp050469 Wray, 2012, Young adults' perceptions about established and emerging tobacco products: Results from eight focus groups, Nicotine & Tobacco Research, 14, 184, 10.1093/ntr/ntr168 Zeller, 2013, Reflections on the 'endgame' for tobacco control, Tobacco Control, 22, i40, 10.1136/tobaccocontrol-2012-050789